Literature DB >> 2009875

Isolation of vancomycin-resistant enterococci in haematologic patients.

H F Guiot1, W E Peetermans, F W Sebens.   

Abstract

After the occurrence of septicaemia with a vancomycin-resistant Enterococcus faecalis strain in a patient, it was decided to determine the number of carriers of vancomycin-resistant cocci among haematologic patients. During a period of six months 135 stool samples from 25 children, and 400 samples from 70 adults were studied. All samples from the children were negative for vancomycin-resistant cocci. Nine of the adult patients had cultures positive for cocci, all identified as enterococci, which were highly resistant to vancomycin (MIC greater than 250 micrograms/ml), sensitive to amoxicillin, moderately resistant to gentamicin, slightly resistant to teicoplanin, and sensitive to daptomycin. None of these patients had been given vancomycin prior to the isolation of the vancomycin-resistant enterococci.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2009875     DOI: 10.1007/bf01967094

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.

Authors:  W G Peters; R Willemze; L P Colly; H F Guiot
Journal:  Neth J Med       Date:  1987-02       Impact factor: 1.422

2.  Comparison of physiologic tests used to identify non-beta-hemolytic aerococci, enterococci, and streptococci.

Authors:  S S Fertally; R Facklam
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

3.  In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.

Authors:  L de la Maza; K L Ruoff; M J Ferraro
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Alpha-hemolytic streptococci: clinical significance in the cancer patient.

Authors:  P A Pizzo; S Ladisch; F G Witebsky
Journal:  Med Pediatr Oncol       Date:  1978

5.  Increasing incidence of Gram-positive sepsis in cancer patients.

Authors:  P A Pizzo; S Ladisch; R M Simon; F Gill; A S Levine
Journal:  Med Pediatr Oncol       Date:  1978

6.  Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria.

Authors:  R Facklam; D Hollis; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

7.  Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study.

Authors:  H F Guiot; P J van den Broek; J W van der Meer; R van Furth
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

8.  Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.

Authors:  D M Shlaes; A Bouvet; C Devine; J H Shlaes; S al-Obeid; R Williamson
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

9.  Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin.

Authors:  M Rozenberg-Arska; A Dekker; L Verdonck; J Verhoef
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

10.  Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures.

Authors:  H F Guiot; A V Helmig-Schurter; J W van der Meer; R van Furth
Journal:  Scand J Infect Dis       Date:  1986
View more
  7 in total

Review 1.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

2.  Neonatal bacteremia due to high level aminoglycoside resistant (HLAR) enterococci.

Authors:  K G Bhat; C Paul; M G Bhat
Journal:  Indian J Pediatr       Date:  1997 Jul-Aug       Impact factor: 1.967

3.  Febrile neutropenic events in cancer patients: treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours.

Authors:  M Nobbenhuis; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Selective medium for screening for vancomycin-resistant enterococci in faeces.

Authors:  G G Rao; K Ghanekar; F Ojo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

5.  New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci.

Authors:  J M Swenson; M J Ferraro; D F Sahm; P Charache; F C Tenover
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

6.  Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1.

Authors:  B M Willey; B N Kreiswirth; A E Simor; Y Faur; M Patel; G Williams; D E Low
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

7.  Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.

Authors:  H F Guiot; L J Corel; J M Vossen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.